
Keywords: SUT; single-use technology; CMOs; contract manufacturing organisation(s); mAb; monoclonal antibody; BSL; biosafety level; CIP; cleaning-in-place; SIP; sterilisation-in-place; WFI; water for injection; DSP; downstream processing; CHO; Chinese hamster ovary